Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep63 | Bone and Calcium | ECE2020

An atypical presentation of a typical aetiology

Kapoor Ashutosh , Ali Sadaf , Wahab Furat

Introduction: Primary hyperparathyroidism (P-HPT) is a common endocrine disorder that occurs as result of adenomas (80–85%), hyperplasia (10–15%), atypical adenoma or carcinomas (<1%). Atypical parathyroid adenoma (APA) is a rare entity and represents intermediate group of parathyroid neoplasms of uncertain malignant potential with some atypical histological features.Case details: We report a case of a 34-year male, with a background of h...

ea0082p3 | Poster Presentations | SFEEU2022

Rare Cause of hypopituitarism –A diagnostic dilemma! Beyond hormones

Ali Sadaf , Mumdzic Enis , Kabuli Asim , Younis Gosal David

Case history: We report an interesting case of a rare cause of hypopituitarism where our patient presented to the hospital with acute onset headache, vomiting, and feeling generally unwell. Investigations/Results: On routine bloods, he was found to have hyponatremia. On further workup of hyponatremia, he had low morning cortisol which was confirmed as secondary adrenal insufficiency on dynamic function testing. He was also deficient in gonadotrophins alo...

ea0094p54 | Metabolism, Obesity and Diabetes | SFEBES2023

Unveiling the metabolic benefits of GLP-1 analogues in alström syndrome: implications for monogenic syndromic obesity management

Ali Sadaf , Paisey Richard , da Silva Xavier Gabriela , Hiwot Tarekegn

Background: Glucagon-like-peptide-1 (GLP-1) has been shown to improve body weight and glycaemic control in patients with common obesity and type 2 diabetes. Whether it confers the same metabolic benefits in monogenic syndromic obesity is unknown. This observational study aimed to examine the real-world efficacy of GLP-1 analogues in Alström syndrome (ALMS), a form of monogenic obesity.Method: We screened all 72 UK a...